Navis Clinical Laboratories is focused on innovative, cutting-edge research and development to aid in the diagnosis, treatment, management and prevention of disease. We provide laboratory testing solutions, including toxicology, clinical blood and molecular testing, for healthcare providers to help reduce suffering and save the lives of people with substance use disorder, mental health conditions, chronic pain, and other acute and chronic diseases, including HIV/AIDS, hepatitis, sexually transmitted infections (STIs), urinary tract infections (UTIs), respiratory infections and antibiotic resistant infections.

Navis launched in February of this year and currently owns three state-of-the-art laboratories located in New York, Washington and Massachusetts, allowing it to provide services nationally to healthcare practices. Although Navis is new, our laboratories have a long history of clinical and operational excellence and superior client service. Our New York laboratory was originally founded in 2008 as American Forensic Toxicology Services (AFTS) by Navis CEO and President Richard Stripp, Ph.D. The Washington laboratory began operating in 2003 and the Worcester laboratory was founded in 2010.

Our name is derived from the Latin word for “navigate” and was chosen because it represents our guiding principle—navigating our clients and patients through challenging times. The symbol in our logo evokes tools that have been used for centuries for direction and accuracy, the guiding light of the North Star and the compass.